LatusPet Publishes Study on AI Blood Test for Multi-Disease Screening in Dogs

July 01, 2026
LatusPet, a University of Oxford biotech startup, has published a peer-reviewed study demonstrating that its SINO platform can detect multiple diseases in dogs from a single blood sample with over 90% accuracy.

LatusPet, a biotech startup from University of Oxford, announced in a press release the publication of a peer-reviewed study in Frontiers in Veterinary Science showing that its SINO platform can screen for multiple diseases in dogs using a single blood sample.

The platform combines blood NMR metabolomic analysis with machine learning to detect cancer, cardiovascular disease, and assess overall health in dogs with a diagnostic accuracy of over 90%. The study involved 139 dogs from veterinary centers in Italy and was led by Professor Riccardo Finotello of Link University in collaboration with Oxford scientists.

Unlike traditional studies that compare one disease to healthy animals, this research tested each condition against a mix of other diseases and healthy subjects, reflecting real clinical scenarios. The technology was built specifically for dogs, with plans to expand testing to additional diseases and species.

LatusPet stated that it is now extending trials to larger cohorts and seeking veterinary partners to implement the screening platform in routine clinical practice.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

07/01
ALR Technologies to Acquire CGM Medical Technology for $45 Million and 200 Million Shares
07/01
Inductive Bio Connects ADMET Prediction Models to Claude for Drug Discovery
07/01
Basecamp Research Integrates EDEN Models into Claude Science for Antibiotic and Vaccine Design
07/01
SciBase Files FDA 510(k) to Expand Nevisense Use for Non-Melanoma Skin Cancer
07/01
PreOncology Launches AI-Based Early Cancer Detection Program

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like